Theradiag Acquires miRNA Firm Prestizia | GenomeWeb

NEW YORK (GenomeWeb News) – French theranostics and in vitro diagnostics company Theradiag announced today it is acquiring biotech firm Prestizia for an undisclosed amount.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.